Difference between revisions of "deLemus"

From
Jump to navigation Jump to search
Line 3: Line 3:
  
  
−
<html><iframe width="1200" height="1000" src="<html><iframe width="1200" height="1000" src="https://docs.google.com/spreadsheets/d/1K2tkCZoOMYEE2OOBIRcKi2g-4mkiQajWussCh08U1yI/edit#gid=0&single=true"></iframe></html>
+
<html><iframe width="1200" height="1000" src="<html><iframe width="1200" height="1000" src="https://docs.google.com/spreadsheets/d/1K2tkCZoOMYEE2OOBIRcKi2g-4mkiQajWussCh08U1yI/edit#gid=0"></iframe></html>
  
 
== '''<big>SARS-CoV-2 Articles Collection</big>''' ==
 
== '''<big>SARS-CoV-2 Articles Collection</big>''' ==

Revision as of 11:51, 22 February 2022

Current Analysis of SARS-CoV-2 from GISAID Database

SARS-CoV-2 Articles Collection

No Name Link Code
1 The GISAID Database https://www.gisaid.org/ 0
4 Nexstrain SARS-CoV-2 resources https://nextstrain.org/sars-cov-2/ 0
14 A novel phosphorylation site in SARS-CoV-2 nucleocapsid regulates its RNA-binding capacity and phase separation in host cells https://academic.oup.com/jmcb/advance-article/doi/10.1093/jmcb/mjac003/6510820?login=false#/ 0
34 Airborne transmission of respiratory viruses https://www.science.org/doi/10.1126/science.abd9149/ 0
36 SARS-CoV-2 infection in free-ranging white-tailed deer https://www.nature.com/articles/s41586-021-04353-x?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 0
41 Do childhood colds help the body respond to COVID? https://www.nature.com/articles/d41586-021-03087-0?utm_source=twt_nat&utm_medium=social&utm_campaign=nature/ 0
42 Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort https://www.science.org/doi/10.1126/scitranslmed.abj7521?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 0
43 Immune memory from SARS-CoV-2 infection in hamsters provides variant-independent protection but still allows virus transmission https://www.science.org/doi/10.1126/sciimmunol.abm3131?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 0
47 Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses https://www.science.org/doi/10.1126/sciimmunol.abl5842?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 0
59 Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection https://www.nature.com/articles/s41591-021-01540-1?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_NRJournals/ 0
65 Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates https://www.science.org/doi/full/10.1126/science.abj0299?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 0
66 How do vaccinated people spread Delta? What the science says https://www.nature.com/articles/d41586-021-02187-1?utm_source=twt_nat&utm_medium=social&utm_campaign=nature/ 0
72 Boosting stem cell immunity to viruses https://www.science.org/doi/10.1126/science.abj5673/ 0
73 Targeting aging cells improves survival https://www.science.org/doi/10.1126/science.abi4474/ 0
74 After the pandemic: perspectives on the future trajectory of COVID-19 https://www.nature.com/articles/s41586-021-03792-w?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 2
87 Hybrid immunity https://www.science.org/doi/10.1126/science.abj2258/ 0
93 How your DNA may affect whether you get COVID-19 or become gravely ill https://www.sciencenews.org/article/coronavirus-covid-how-dna-genetic-risk-infection-severe-illness/ 0
95 Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection https://www.nature.com/articles/s41586-021-03696-9?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 0
96 How were the first treatments for COVID identified? https://www.compoundchem.com/2021/06/16/recovery-trial// 0
100 Antibody sugars are bittersweet https://www.science.org/doi/10.1126/science.abj0435/ 0
101 CRISPR diagnostics https://www.science.org/doi/10.1126/science.abi9335/ 0
104 Complement control for COVID-19 https://www.science.org/doi/10.1126/sciimmunol.abj1014/ 0
109 Estimating infectiousness throughout SARS-CoV-2 infection course https://www.science.org/doi/10.1126/science.abi5273/ 0
115 Face masks effectively limit the probability of SARS-CoV-2 transmission https://www.science.org/doi/10.1126/science.abg6296/ 0
126 How COVID broke the evidence pipeline https://www.nature.com/articles/d41586-021-01246-x?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 0
131 It’s time to consider a patent reprieve for COVID vaccines https://www.nature.com/articles/d41586-021-00863-w?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 0
132 SARS-CoV-2 transmission without symptoms https://www.science.org/doi/10.1126/science.abf9569/ 0
135 Five reasons why COVID herd immunity is probably impossible https://www.nature.com/articles/d41586-021-00728-2?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 0
137 Rare COVID reactions might hold key to variant-proof vaccines https://www.nature.com/articles/d41586-021-00722-8?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 0
138 Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 https://www.nature.com/articles/s41586-021-03426-1?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 0
139 Cell Press Coronavirus Resource Hub https://www.cell.com/COVID-19/ 0
140 Nexstrain SARS-CoV-2 resources https://nextstrain.org/sars-cov-2// 0
141 CoVariants https://covariants.org// 0
142 The GISAID Database https://www.gisaid.org// 0
143 UniProt (Data Retrieving) https://www.uniprot.org/uploadlists// 0
161 Multiple Sequence Alignment https://www.ebi.ac.uk/Tools/msa/clustalo// 0
6 InterPro (List of Protein Family) https://www.ebi.ac.uk/interpro// 0
7 More evidence suggests COVID-19 was in the US by Christmas 2019 https://apnews.com/article/more-evidence-covid-in-US-by-Christmas-2019-11346afc5e18eee81ebcf35d9e6caee2/ 0
9 A COVID Vaccine for All https://www.scientificamerican.com/article/a-covid-vaccine-for-all// 1
10 Single-cell immunology of SARS-CoV-2 infection https://www.nature.com/articles/s41587-021-01131-y?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_NRJournals/ 1
11 Innate immunological pathways in COVID-19 pathogenesis https://www.science.org/doi/10.1126/sciimmunol.abm5505?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 1
15 Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity https://www.science.org/doi/10.1126/scitranslmed.abm7853?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 1
22 COVID-19 vaccine side effects: The positives about feeling bad https://www.science.org/doi/10.1126/sciimmunol.abj9256?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 1
24 COVID-19 vaccine breakthrough infections https://www.science.org/doi/10.1126/science.abl8487?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 1
25 B.1.1.529 escapes the majority of SARS-CoV-2 neutralizing antibodies of diverse epitopes https://www.biorxiv.org/content/10.1101/2021.12.07.470392v1/ 1
26 Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy? https://www.nature.com/articles/s41577-021-00656-2?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_NRJournals/ 1
32 Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals https://www.science.org/doi/10.1126/scitranslmed.abi8961?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 1
33 mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern https://www.science.org/doi/10.1126/science.abm0829?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 1
39 Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures https://www.science.org/doi/10.1126/sciadv.abl6096/ 1
44 Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2 https://www.science.org/doi/10.1126/sciimmunol.abk3070?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 1
48 A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice https://www.science.org/doi/10.1126/scitranslmed.abj7125?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 1
50 Scent of a vaccine https://www.science.org/doi/10.1126/science.abg9857?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 1
52 A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19 https://www.nature.com/articles/s41467-021-25480-z/ 1
53 High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape https://www.nature.com/articles/s41586-021-04005-0?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 1
54 Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern https://www.science.org/doi/10.1126/scitranslmed.abj5413?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 1
58 Broad betacoronavirus neutralization by a stem helix–specific human antibody https://www.science.org/doi/10.1126/science.abj3321?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 1
61 Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice https://www.science.org/doi/10.1126/science.abi4506?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 1
62 Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants https://www.science.org/doi/10.1126/science.abh1766/ 1
63 Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers https://www.science.org/doi/10.1126/sciimmunol.abe9950/ 1
64 Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants https://www.nature.com/articles/s41467-021-24909-9?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_NRJournals/ 1
67 Broad sarbecovirus neutralization by a human monoclonal antibody https://www.nature.com/articles/s41586-021-03817-4?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 1
69 Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine https://www.nature.com/articles/s41586-021-03841-4?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 1
70 Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination https://www.nature.com/articles/s41591-021-01449-9?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_NRJournals/ 1
71 Systems vaccinology of the BNT162b2 mRNA vaccine in humans https://www.nature.com/articles/s41586-021-03791-x?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 1
75 A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters https://www.science.org/doi/10.1126/scitranslmed.abg1143/ 1
76 Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2 https://www.science.org/doi/full/10.1126/science.abg5827/ 1
83 Engineered single-domain antibodies tackle COVID variants https://www.nature.com/articles/d41586-021-01721-5?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 1
84 CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19 https://www.science.org/doi/10.1126/sciimmunol.abg5669/ 1
89 Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals https://www.nature.com/articles/s41591-021-01413-7?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_NRJournals/ 1
92 Artificial Proteins Never Seen in the Natural World Are Becoming New COVID Vaccines and Medicines https://www.scientificamerican.com/article/artificial-proteins-never-seen-in-the-natural-world-are-becoming-new-covid-vaccines-and-medicines// 1
94 Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2 https://www.science.org/doi/full/10.1126/science.abi4708/ 1
98 Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom https://www.nature.com/articles/s41591-021-01410-w?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_NRJournals/ 1
103 Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans https://www.nature.com/articles/s41586-021-03681-2?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 1
106 BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans https://www.nature.com/articles/s41586-021-03653-6?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 1
108 SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients https://www.science.org/doi/10.1126/sciimmunol.abj1750/ 1
112 Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues https://www.science.org/doi/10.1126/science.abf6648/ 1
114 A network analysis of COVID-19 mRNA vaccine patents https://www.nature.com/articles/s41587-021-00912-9?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_NRJournals/ 1
117 High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages https://www.science.org/doi/10.1126/scitranslmed.abf8654/ 1
119 COVID-19–related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters https://www.science.org/doi/10.1126/scitranslmed.abf8396/ 1
121 How Pfizer Makes Its Covid-19 Vaccine https://www.nytimes.com/interactive/2021/health/pfizer-coronavirus-vaccine.html?smid=tw-share/ 1
123 A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice https://www.biorxiv.org/content/10.1101/2021.04.27.441655v1/ 1
124 Adjuvanting a subunit COVID-19 vaccine to induce protective immunity https://www.nature.com/articles/s41586-021-03530-2/ 1
129 The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD https://www.biorxiv.org/content/10.1101/2021.04.14.439844v1/ 1
136 The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates https://www.science.org/doi/10.1126/scitranslmed.abf1906/ 1
145 Immunity to SARS-CoV-2 variants of concern https://www.science.org/doi/10.1126/science.abg7404/ 1
146 Lilly COVID-19 Antibody Combination Shows 87% Risk Reduction in Phase III Trial https://www.genengnews.com/news/lilly-covid-19-antibody-combination-shows-87-risk-reduction-in-phase-iii-trial// 1
148 Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 https://www.ijbs.com/v16p1718.htm/ 1
149 Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides https://pubs.rsc.org/en/content/articlelanding/2021/md/d0md00385a#!divAbstract/ 1
151 SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma https://www.nature.com/articles/s41591-021-01285-x/ 1
153 A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein https://www.nature.com/articles/s41467-020-20602-5/ 1
2 Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 https://www.nature.com/articles/s41591-021-01325-6/ 1
12 The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in non-human primates https://stm.sciencemag.org/content/early/2021/04/05/scitranslmed.abf1906.full/ 1
35 Evolutionary trajectory of SARS-CoV-2 and emerging variants https://virologyj.biomedcentral.com/articles/10.1186/s12985-021-01633-w/ 2
45 Dynamic Expedition of Leading Mutations in SARS-CoV-2 Spike Glycoproteins https://www.biorxiv.org/content/10.1101/2021.12.29.474427v1/ 2
46 Mapping the proteo-genomic convergence of human diseases https://www.science.org/doi/10.1126/science.abj1541?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 2
49 From Alpha to Epsilon: Consortium study illuminates surfaces of Spike most resistant to antibody escape https://www.lji.org/news-events/news/post/from-alpha-to-epsilon-consortium-study-illuminates-surfaces-of-spike-most-resistant-to-antibody-escape// 2
91 Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study https://www.science.org/doi/10.1126/science.abh2315#.YVFR4Ob9en8.twitter/ 2
99 The biological and clinical significance of emerging SARS-CoV-2 variants https://www.nature.com/articles/s41576-021-00408-x?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_NRJournals/ 2
152 Evolution of a virus-like architecture and packaging mechanism in a repurposed bacterial protein https://www.science.org/doi/10.1126/science.abg2822/ 2
156 Spike mutation T403R allows bat coronavirus RaTG13 to use human ACE2 https://www.biorxiv.org/content/10.1101/2021.05.31.446386v1/ 2
16 Evolution of antibody immunity to SARS-CoV-2 https://www.nature.com/articles/s41586-021-03207-w/ 2
17 Evolution of antibody immunity to SARS-CoV2 https://www.nature.com/articles/s41586-021-03207-w/ 2
19 Innovative X-ray imaging shows COVID-19 can cause vascular damage to the heart https://medicalxpress.com/news/2021-12-x-ray-imaging-covid-vascular-heart.html/ 3
21 Bacteriophage self-counting in the presence of viral replication https://www.pnas.org/content/118/51/e2104163118/ 3
37 Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody binding https://www.cell.com/cell-reports/fulltext/S2211-1247(21)01652-1#.YbBFgwgnRMI.twitter/ 3
40 Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain https://www.science.org/doi/10.1126/science.abl6251?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 3
51 Ensemble cryo-electron microscopy reveals conformational states of the nsp13 helicase in the SARS-CoV-2 helicase replication-transcription complex https://www.biorxiv.org/content/10.1101/2021.11.10.468168v1/ 3
56 Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant https://www.science.org/doi/10.1126/science.abl9463?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 3
57 Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme https://www.science.org/doi/full/10.1126/science.abi9310?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 3
78 Water-Triggered, Irreversible Conformational Change of SARS-CoV-2 Main Protease on Passing from the Solid State to Aqueous Solution https://pubs.acs.org/doi/10.1021/jacs.1c05301/ 3
79 A glycan gate controls opening of the SARS-CoV-2 spike protein https://www.nature.com/articles/s41557-021-00758-3?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_NRJournals/ 3
80 The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells https://www.nature.com/articles/s41467-021-24342-y?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_NRJournals/ 3
81 Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies https://www.science.org/doi/10.1126/sciadv.abh3032/ 3
82 Mn2+ coordinates Cap-0-RNA to align substrates for efficient 2′-O-methyl transfer by SARS-CoV-2 nsp16 https://www.science.org/doi/10.1126/scisignal.abh2071/ 3
85 A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors https://www.cell.com/biophysj/fulltext/S0006-3495(21)00146-6/ 3
86 Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome https://www.science.org/doi/10.1126/science.abf3546/ 3
88 Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques https://www.nature.com/articles/s41586-021-03732-8?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 3
90 Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs https://www.nature.com/articles/s41594-021-00619-0?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_NRJournals/ 3
102 A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19 https://www.nature.com/articles/s42255-021-00425-4?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_NRJournals/ 3
105 Improving SARS-CoV-2 structures: Peer review by early coordinate release https://www.cell.com/biophysj/fulltext/S0006-3495(21)00046-1/ 3
107 Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core https://www.biorxiv.org/content/10.1101/2021.05.24.445443v2/ 3
110 Revealing the spike's real shape https://www.science.org/content/blog-post/revealing-spike-s-real-shape/ 3
113 SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes https://www.nature.com/articles/s41467-021-22905-7?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_NRJournals/ 3
116 X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease https://www.science.org/doi/10.1126/science.abf7945/ 3
118 Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State https://www.science.org/doi/10.1126/scitranslmed.abf0202/ 3
120 COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets https://www.nature.com/articles/s41586-021-03570-8?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 3
125 Structural biology in the time of COVID-19: perspectives on methods and milestones https://journals.iucr.org/m/issues/2021/03/00/mf5052/index.html/ 3
127 Massively Multiplexed Affinity Characterization of Therapeutic Antibodies Against SARS-CoV-2 Variants https://www.biorxiv.org/content/10.1101/2021.04.27.440939v1/ 3
128 Fine-tuning the Spike: Role of the nature and topology of the glycan shield in the structure and dynamics of the SARS-CoV-2 S https://www.biorxiv.org/content/10.1101/2021.04.01.438036v2/ 3
133 Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites https://www.biorxiv.org/content/10.1101/2021.04.01.438087v1/ 3
134 Electrostatic interactions between the SARS-CoV-2 virus and a charged electret fibre https://pubs.rsc.org/en/content/articlelanding/2021/sm/d1sm00232e/ 3
144 How SARS-CoV-2’s Sugar-Coated Shield Helps Activate the Virus https://www.biophysics.org/news-room/how-sars-cov-2s-sugar-coated-shield-helps-activate-the-virus/ 3
147 Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex https://www.biorxiv.org/content/10.1101/2021.03.13.435256v1/ 3
155 The emerging plasticity of SARS-CoV-2 https://science.sciencemag.org/content/371/6536/1306.full/ 3
157 Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 https://science.sciencemag.org/content/371/6531/850/ 3
3 Identification of lection receptor for conserved SARS-C0V-2 glycosilation https://www.biorxiv.org/content/10.1101/2021.04.01.438087v1/ 3
5 Computational epitope map of SARS-CoV-2 spike protein https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1008790/ 3
8 Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron https://www.nature.com/articles/s41586-022-04399-5#Echobox=1641674359/ 4
13 Structural basis of Omicron neutralization by affinity-matured public antibodies https://www.biorxiv.org/content/10.1101/2022.01.03.474825v1/ 4
18 The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism https://www.gla.ac.uk/media/Media_829360_smxx.pdf/ 4
20 Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant https://www.science.org/doi/10.1126/science.abl9551?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 4
23 CryoEM structure of Omicron (B.1.1.529) variant spike protein in complex with human ACE2 reveals new salt bridges formed by mutated residues R498 and R493 in the RBD and residues D38 and E35, respectively, in ACE2. https://twitter.com/cryoem_UBC/status/1471390036851511299/ 4
27 SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals https://www.medrxiv.org/content/10.1101/2021.12.08.21267491v1/ 4
28 Modelling the potential consequences of the Omicron SARS-CoV-2 variant in England https://cmmid.github.io/topics/covid19/omicron-england.html/ 4
29 Omicron and Delta Variant of SARS-CoV-2: A Comparative Computational Study of Spike protein https://www.biorxiv.org/content/10.1101/2021.12.02.470946v1/ 4
30 Where did ‘weird’ Omicron come from? https://www.science.org/content/article/where-did-weird-omicron-come?utm_campaign=NewsfromScience&utm_source=Social&utm_medium=Twitter/ 4
31 The Omicron SARSCoV2 mutations in each gene and the drugs, candidates, & vaccines that target them. The 3CL protease and RNA polymerase have only 1 mutation each (unlike spike, which has >30); the drug candidates targeting them might be more likely to retain efficacy. https://twitter.com/davidrliu/status/1464714206150807559/photo/1/ 4
38 The mutation map of the 5 Variants of Concern https://covariants.org/shared-mutations/ 4
55 Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern/ 4
60 Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants https://www.science.org/doi/10.1126/science.abl8506?utm_campaign=SciMag&utm_source=Social&utm_medium=Twitter/ 4
68 The mutation that helps Delta spread like wildfire https://www.nature.com/articles/d41586-021-02275-2?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 4
77 SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern https://www.science.org/doi/10.1126/science.abi7994/ 4
97 Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence https://www.science.org/doi/full/10.1126/science.abj0113/ 4
111 Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization https://www.nature.com/articles/s41586-021-03777-9?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 4
122 Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets https://www.science.org/doi/10.1126/science.abi5224/ 4
130 Coronavirus variants are spreading in India — what scientists know so far https://www.nature.com/articles/d41586-021-01274-7?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature/ 4
150 Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil https://www.science.org/doi/10.1126/science.abh2644/ 4
154 A novel variant of interest of SARS-CoV-2 with multiple spike mutations detected through travel surveillance in Africa https://www.krisp.org.za/publications.php?pubid=330/ 4
158 Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 https://www.nature.com/articles/s41586-021-03398-2/ 4
159 Development of potency, breadth and resilience to viral escape mutation in SARS-CoV-2 neutralizing anitbodies https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1/ 4
160 UK+ South African + Brazil Variants/ https://www.youtube.com/watch?v=OYgVmOLF2mY/ 4
162 Summary of Clinical Data on New Coronavirus Variant, Suggests Humans can still win the Long war https://m.weibo.cn/status/4647414625212687?sourceType=weixin&from=10AC195010&wm=4260_0001&featurecode=newtitle/ 4
163 Delta Variant US confirmed rate doubles in 7 days! https://mp.weixin.qq.com/s/8lRnwUUz_3dV7QMtfg2s4w/ 4
164 Delta variant isn’t over, Delta+ variant strikes again https://m.weibo.cn/status/4650675290506335?sourceType=weixin&from=10B6195010&wm=2468_1001&featurecode=newtitle/ 4
165 Delta coronavirus variant: scientists brace for impact https://www.nature.com/articles/d41586-021-01696-3?utm_source=twt_nat&utm_medium=social&utm_campaign=nature/ 4
166 Menacing: What is the new crown Delta mutant, and how can we respond? https://mp.weixin.qq.com/s/g9gPLEN6R02F49eRGGSuAA/ 4
167 Race to understand Sars-CoV-2 variants amid fears virus might evade vaccines https://www.chemistryworld.com/news/race-to-understand-sars-cov-2-variants-amid-fears-virus-might-evade-vaccines/4013891.article/ 4
Retrieved from "https://wiki.laviebay.hkust.edu.hk/deLemus/index.php?title=deLemus&oldid=318"